Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin for prevention of primary postpartum haemorrhage after vaginal delivery
PACTR202410557388132Not yet recruiting
- Sponsor
- Ayanda Tolulope Oluwamayowa
- Start
- Nov 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in postpartum hemorrhage (PPH) comparing Carbetocin with Oxytocin control (2 arms). Primary endpoint: Primary postpartum haemorrhage based on blood loss threshold. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
carbetocinoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202410557388132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202410557388132.